EGFR and breast cancer: These cell lines represent the patient-derived TNBC subset from the TCGA dataset described above: the PaSSS of MDA-MB-468 included EGFR and estrogen receptor, ER, as central targets, thereby corresponding to ~31% TNBC tissues in the TCGA breast cancer subset (Figure 2A,B).